Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Country:  U.S.A.
Trial Type:  Supportive care
Treatment/Intervention:  nausea and vomiting therapy
Results 1-6 of 6 for your search:
Start Over
Antiemetic Therapy with or without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Receiving Highly Emetogenic Chemotherapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221301, NCI-2014-00446, NCT02116530
Ondansetron with or without Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Gliomas
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: Pro00031206, NCI-2013-00520, NCT01450826
Fosaprepitant Dimeglumine, 5HT3 Receptor Antagonists, and Dexamethasone in Reducing Nausea and Vomiting in Patients with Germ Cell Tumors Undergoing Chemotherapy with Cisplatin
Status: Active
Phase: Phase II
Type: Supportive care
Age: 15 and over
Trial IDs: QL12-153, NCI-2013-00278, 1211010041, 1211010041R001, HOG QL12-153, NCT01736917
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients with Breast Cancer Undergoing Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 1B-11-5, NCI-2012-01170, HS-11-00443, NCT01649258
Neuromuscular Electrical Stimulation of Acupoint P6 in Preventing Nausea and Vomiting after Surgery in Patients Undergoing Breast Cancer Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 2015-0170, NCI-2015-01519, NCT02473042
Start Over